In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS

Neuroradiology

Volumn 54, Issue 7, 2012, Pages 771-780

  Saini, Jitender ^a   Bagepally, Bhavani Shankara ^a   Sandhya, Mangalore ^a   Pasha, Shaik Afsar ^a   Yadav, Ravi ^a   Pal, Pramod Kumar ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

DTI; Progressive supranuclear palsy; TBSS

Indexed keywords

AGED; ANISOTROPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; HUMAN; MALE; MESENCEPHALON; PARIETAL LOBE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROSPECTIVE STUDY; RATING SCALE; SUPERIOR CEREBELLAR PEDUNCLE; TECTUM; THALAMUS; WHITE MATTER;

ANISOTROPY; CASE-CONTROL STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; PROSPECTIVE STUDIES; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84862839973     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-011-0983-7     Document Type: Article

References (49)

1. Litvan I (2003) Update on epidemiological aspects of progressive supranuclear palsy. Mov Disord 18(Suppl 6):S43-S50 (Pubitemid 37185195)
2. Carrilho PE, Barbosa ER (2002) Progressive supranuclear palsy in a sample of Brazilian population: clinical features of 16 patients. Arq Neuropsiquiatr 60(4):917-922 (Pubitemid 35439733)
3. Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJU (2003) Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 60(6):910-916 (Pubitemid 36348920)
4. Lubarsky M, Juncos JL (2008) Progressive supranuclear palsy: a current review. Neurologist 14:79-88 (Pubitemid 351366940)
5. Morris HR, Wood NW, Lees AJ (1999) Progressive supranuclear palsy (Steele-Richardson-Olszewski disease). Postgrad Med J 75:579-584 (Pubitemid 29452585)
6. Price S, Paviour D, Scahill R, Stevens J, Rossor M, Lees A, Fox N (2004) Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 23(2):663-669 (Pubitemid 39370617)
7. Brenneis C, Seppi K, Schocke M, Benke T, Wenning GK, Poewe W (2004) Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 75(2):246-249 (Pubitemid 38183532)
8. Padovani A, Borroni B, Brambati SM, Agosti C, Broli M, Alonso R Scifo P, Bellelli G, Alberici A, Gasparotti R, Perani D (2006) Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 77(4):457-463
9. Cordato NJ, Duggins AJ, Halliday GM, Morris JG, Pantelis C (2005) Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 128:1259-1266 (Pubitemid 40826180)
10. Agosta F, Kostić VS, Galantucci S, Mesaros S, Svetel M, Pagani E, Stefanova E, Filippi M (2010) The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP - parkinsonism: a VBM-DARTEL study. Eur J Neurosci 32(4):640-647
11. Whitwell JL, Avula R, Master A, Vemuri P, Senjem ML, Jones DT, Jack CR Jr, Josephs KA (2011) Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord 17(8):599-605
12. Whitwell JL, Master AV, Avula R, Kantarci K, Eggers SD, Edmonson HA, Jack CR Jr, Josephs KA (2011) Clinical correlates of WM tract degeneration in progressive supranuclear palsy. Arch Neurol 68(6):753-760
13. Wang J, Wai Y, Lin WY, Ng S, Wang CH, Hsieh R, Hsieh C, Chen RS, Lu CS (2010) Microstructural changes in patients with progressive supranuclear palsy: a diffusion tensor imaging study. J Magn Reson Imaging 32(1):69-75
14. Kvickström P, Eriksson B, van Westen D, Lätt J, Elfgren C, Nilsson C (2011) Selective frontal neurodegeneration of the inferior fronto-occipital fasciculus in progressive supranuclear palsy (PSP) demonstrated by diffusion tensor tractography. BMC Neurol 11:13
15. Knake S, Belke M, Menzler K, Pilatus U, Eggert KM, Oertel WH, Stamelou M, Höglinger GU (2010) In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord 25(9):1232-1238
16. Erbetta A, Mandelli ML, Savoiardo M, Grisoli M, Bizzi A, Soliveri P, Chiapparini L, Prioni S, Bruzzone MG, Girotti F (2009) Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration. AJNR Am J Neuroradiol 30(8):1482-1487
17. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31:1487-1505
18. Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44:83-98
19. Jellinger KA (2008) Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 5:339-346
20. Morris HR, Gibb G, Katzenschlager R, Wood N, Hanger DP, Strand C, Lashley T, Daniel SE, Lees AJ, Anderton BH, Revesz T (2002) Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain 125:969-975 (Pubitemid 34464609)
21. Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP - parkinsonism. Brain 128:1247-1258 (Pubitemid 40826179)
22. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47(1):1-9 (Pubitemid 26243849)
23. Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130:1552-1565 (Pubitemid 47355915)
24. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427-442
25. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189-198
26. Fahn S, Elton RL (1987) UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson's disease. Macmillan, Florham Park, pp 153-163
27. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L, Kochunov PV, Nickerson D, Mikiten SA, Fox PT (2000) Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10(3):120-131 (Pubitemid 30456920)
28. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N (2002) Accurate, robust and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17(1):479-489
29. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy R, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(S1):208-219
30. Acosta-Cabronero J, Williams GB, Pengas G, Nestor PJ (2010) Absolute diffusivities define the landscape of WM degeneration in Alzheimer's disease. Brain 133(Pt 2):529-539
31. Beaulieu C (2002) The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed 15(7-8):435-455 (Pubitemid 36054508)
32. Della Nave R, Ginestroni A, Diciotti S, Salvatore E, Soricelli A, Mascalchi M (2011) AD is increased in the degenerating superior cerebellar peduncles of Friedreich's ataxia. Neuroradiology 53 (5):367-372
33. Weaver KE, Richards TL, Liang O, Laurino MY, Samii A, Aylward EH (2009) Longitudinal diffusion tensor imaging in Huntington's disease. Exp Neurol 216(2):525-529
34. Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ, Revesz T (2007) Pathological tau burden and distribution distinguishes progressive supranuclear palsy - parkinsonism from Richardson's syndrome. Brain 130:1566-1576 (Pubitemid 47355935)
35. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55:97-105 (Pubitemid 26013790)
36. Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246(Suppl 2):II6-II15 (Pubitemid 29467074)
37. Goedert M (2005) Tau gene mutations and their effects. Mov Disord 20(Suppl 12):S45-S52 (Pubitemid 41419554)
38. Zhukareva V, Joyce S, Schuck T, Van Deerlin V, Hurtig H, Albin R, Gilman S, Chin S, Miller B, Trojanowski JQ, Lee VM (2006) Unexpected abundance of pathological tau in progressive supranuclear palsy WM. Ann Neurol 60(3):335-345 (Pubitemid 44520236)
39. Warmuth-Metz M, Naumann M, Csoti I, Solymosi L (2001) Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 58(7):1076-1079 (Pubitemid 32660770)
40. Cosottini M, Ceravolo R, Faggioni L, Lazzarotti G, Michelassi MC, Bonuccelli U, Murri L, Bartolozzi C (2007) Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 116 (1):37-42 (Pubitemid 46976265)
41. Halliday GM, Macdonald V, Henderson JM (2005) A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. Brain 128:2272-2280 (Pubitemid 41407967)
42. Cordato NJ, Pantelis C, Halliday GM, Velakoulis D, Wood SJ, Stuart GW, Currie J, Soo M, Olivieri G, Broe GA, Morris JG (2002) Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 125(Pt 4):789-800 (Pubitemid 34279774)
43. Litvan I (2004) Update on progressive supranuclear palsy. Curr Neurol Neurosci Rep 4:296-302 (Pubitemid 39023099)
44. Kier EL, Staib LH, Davis LM, Bronen RA (2004) MR imaging of the temporal stem: anatomic dissection tractography of the uncinate fasciculus, inferior occipitofrontal fasciculus, and Meyer's loop of the optic radiation. AJNR Am J Neuroradiol 25 (5):677-691 (Pubitemid 38657647)
45. Armstrong RA, Lantos PL, Cairns NJ (2009) Hippocampal pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases. Clin Neuropathol 28(1):46-53
46. Cummings JL (1993) Frontal-subcortical circuits in human behavior. Arch Neurol 50:873-880
47. Henderson JM, Carpenter K, Cartwright H, Halliday GM (2000) Loss of thalamic intralaminar nulei in progressive supranuclear palsy and Parkinsons disease: clinical and therapeutic implications. Brain 123:1410-1421 (Pubitemid 30420941)
48. Rizzo G, Martinelli P, Manners D, Scaglione C, Tonon C, Cortelli P, Malucelli E, Capellari S, Testa C, Parchi P, Montagna P, Barbiroli B, Lodi R (2008) Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain 131:2690-2700
49. Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM (2010) Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord. Dec 13. doi:10.1002/mds.23295